3,422
+2.46%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nippon Shinyaku Co
Its shares trade on Tokyo Stock Exchange under the ticker 4516.T. It has been listed since 4 July 1949. In the fiscal year to 31 March 2026, it reported revenue of ¥170.77bn and net income of ¥29.72bn. At that date it held total assets of ¥346.36bn and shareholders' equity of ¥291.55bn.
Nippon Shinyaku Co., Ltd. engages in the manufacture and sale of pharmaceuticals and foodstuffs. The company is headquartered in Kyoto, Kyoto-Fu. The firm operates in two business segments. The Pharmaceutical segment is involved in the manufacture and sale of urinary system therapeutic agents, blood cancer therapeutic agents, pain, inflammation and allergic therapeutic agents, digestive system therapeutic agents, cardiovascular systems and metabolic therapeutic agents. The Functional Foodstuff segment involves in the manufacture and sale of health food materials, quality stability preservatives, protein preparation, spice and seasoning products. The firm is also involved in the business support business, non-life insurance agency business, as well as the provision of real estate leasing services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 4 Jul 1949
- Employees
- 1,951
- Website
- nippon-shinyaku.co.jp ↗
Leadership
Pay as last reported
- Mr. Shigenobu MaekawaChairman of the Board, Representative Director, since 2006
- Mr. Toru NakaiPresident, Representative Director, since 2019
- Mr. Shozo SanoManaging Director, Chief Director of Sales, since 2010
- Mr. Kazuyuki IwataExecutive Officer, Manager of Nagoya Office in Main Sales Unit
- Mr. Mitsuharu KoizumiExecutive Officer, Senior Director of Sales Planning
- Mr. Keiichi KuwanoExecutive Officer, Director of Drug Discovery Research Institute
- Mr. Katsumi NodaExecutive Officer, Manager of Tokyo Office in Main Sales Unit
- Mr. Yoshizumi TanakaExecutive Officer, Senior Director of Reliability Assurance
- Mr. Masaya TodaExecutive Officer, Senior Director of License
- Mr. Hayato WadaExecutive Officer, Manager of Kansai Office in Main Sales Unit
- Mr. Toru YamaguchiExecutive Officer, Manager of Odawara General Formulation Plant
- Mr. Kazuyuki YamateExecutive Officer, Senior Director of DX
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 78
- Environment
- 82
- Social
- 99
- Governance
- 54
- Direct emissions (scope 1)
- 4,366 t
- Energy emissions (scope 2)
- 8,044 t
- Value chain emissions (scope 3)
- 264,289 t
- Women in the workforce
- 31.2%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Nippon Shinyaku Co Ltd is a well-established company with a strong presence in the market. It has built a reputable brand image over the years, which gives it a competitive advantage.
- The company offers a diverse range of products and services, catering to various industries and customer segments. This diversification helps Nippon Shinyaku Co Ltd to mitigate risks and maximize its market reach.
- Nippon Shinyaku Co Ltd possesses strong technological expertise in its field. This enables the company to develop innovative products, enhance operational efficiency, and stay ahead of its competitors.
Weaknesses
- Nippon Shinyaku Co Ltd has a relatively limited presence in global markets compared to some of its competitors. This hampers its ability to exploit international opportunities and gain a larger market share.
- The company relies heavily on a few key customers for a significant portion of its revenue. Any adverse developments related to these customers can have a substantial impact on Nippon Shinyaku Co Ltd's financial performance.
- Nippon Shinyaku Co Ltd operates in a highly regulated industry. Compliance with various regulations and obtaining necessary approvals can be time-consuming and costly, posing challenges to the company's growth and expansion plans.
Opportunities
- The global healthcare industry is experiencing significant growth. Nippon Shinyaku Co Ltd can capitalize on this trend by expanding its product offerings, targeting emerging markets, and leveraging its expertise to meet the increasing demand for healthcare products.
- Forming strategic partnerships and collaborations with other companies can provide Nippon Shinyaku Co Ltd with access to new technologies, markets, and resources. Such alliances can enhance the company's competitive position and foster innovation.
- Investing in research and development activities can enable Nippon Shinyaku Co Ltd to develop new and improved products, expand its product pipeline, and gain a competitive edge in the market. Continued innovation is vital for the company's long-term success.
Threats
- The industry Nippon Shinyaku Co Ltd operates in is highly competitive. Competition from both established players and new entrants puts pressure on pricing, market share, and profitability. The company needs to continuously differentiate itself to stay ahead.
- Fluctuations in the global economy can impact the purchasing power of consumers and businesses, affecting Nippon Shinyaku Co Ltd's sales and profitability. It is crucial for the company to adopt strategies that are resilient to economic uncertainties.
- Regulations governing the industry Nippon Shinyaku Co Ltd operates in are subject to frequent changes. Complying with new regulations can impose additional costs and administrative burden, potentially affecting the company's operations and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.